SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000912057-01-001162
Filing Date
2001-01-11
Accepted
2001-01-11 00:00:00
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II,L.P.BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF INVESTMENTS L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A a2035011zsc13ga.txt SC 13G/A 21688
2 EXHIBIT 1 a2035011zex-1.txt EX-1 2680
  Complete submission text file 0000912057-01-001162.txt   26786
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Subject) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: SC 13G/A | Act: 34 | File No.: 005-34935 | Film No.: 1507236
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice